The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.
Prostacyclin (PGI2) was given intravenously in doses of 1 to 5 ng/kg/min to eight consecutive patients with end stage peripheral arteriosclerosis and ischaemic ulcers. Seven patients had intense ischaemic pains. Complete or partial healing of ulcers were seen in six cases (complete in three). In those whose ulcers healed (complete or partially) relief of ulcer pain was remarkable. Acute studies of the effect of prostacyclin on skin temperature of ischaemic areas showed no correlation with clinical effects. Seven patients had more or less pronounced subjective side effects, most often flushing, nausea, headache and uneasiness. As we previously have seen equally good healing and pain relieving effects by the administration of prostaglandin E1 without these side effects the latter compound is so far preferred in the treatment of severe peripheral artery disease. Controlled studies of the effect are needed.
D000368:Aged; D001161:Arteriosclerosis / Q000150:complications*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D011464:Epoprostenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007511:Ischemia / Q000209:etiology*; D007866:Leg / Q000098:blood supply; D007871:Leg Ulcer / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D011453:Prostaglandins / Q000627:therapeutic use*; D011458:Prostaglandins E / Q000627:therapeutic use
D011453:Prostaglandins; D011458:Prostaglandins E; D011464:Epoprostenol